Published in Int J Clin Exp Med on August 15, 2015
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Mechanisms of angiogenesis and arteriogenesis. Nat Med (2000) 13.88
Quantitative synthesis in systematic reviews. Ann Intern Med (1997) 11.72
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A (1991) 3.95
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer (2008) 3.46
Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal (2009) 2.03
VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler Thromb Vasc Biol (2008) 1.90
VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res (2003) 1.82
Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases. Ann Surg Oncol (2011) 1.59
Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci (2002) 1.56
Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest (2011) 1.42
Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One (2011) 1.37
Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer (2005) 1.24
The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett (2004) 1.23
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Pancreas (2008) 1.14
Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut (2005) 1.12
Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma. J Formos Med Assoc (2012) 1.10
The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler Thromb Vasc Biol (2007) 1.03
Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol (2005) 1.03
Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma. Cancer Lett (2006) 0.99
Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC Cancer (2011) 0.98
Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1. J Cell Biochem (2008) 0.89
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer. Breast Cancer Res Treat (2012) 0.89
Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer. Dis Colon Rectum (2009) 0.88
The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma. Oncol Rep (2010) 0.87
A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer. Ann Surg Oncol (2013) 0.85
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue. Int J Cancer (2010) 0.85
Placenta growth factor expression has prognostic value in malignant pleural mesothelioma. Ann Thorac Surg (2009) 0.83
Expression of placenta growth factor in colorectal carcinomas. J Korean Soc Coloproctol (2012) 0.81
Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer. Head Neck (2010) 0.81
The controversial role of placental growth factor in tumor growth. Cancer Lett (2011) 0.80
Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients. Endocr Relat Cancer (2013) 0.79
Increased expression of placental growth factor in high-grade endometrial carcinoma. Oncol Rep (2012) 0.78
Preoperative serum placenta growth factor level as a new marker for stage II or III colorectal cancer patients. Turk J Gastroenterol (2012) 0.77
CD105 and placental growth factor--potent prognostic factors in childhood acute lymphoblastic leukaemia. Leuk Res (2012) 0.76